These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7780982)

  • 1. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
    Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
    Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach.
    Baffa R; Negrini M; Mandes B; Rugge M; Ranzani GN; Hirohashi S; Croce CM
    Cancer Res; 1996 Jan; 56(2):268-72. PubMed ID: 8542579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refinement of regional loss of heterozygosity for chromosome 11p15.5 in human breast tumors.
    Winqvist R; Mannermaa A; Alavaikko M; Blanco G; Taskinen PJ; Kiviniemi H; Newsham I; Cavenee W
    Cancer Res; 1993 Oct; 53(19):4486-8. PubMed ID: 8402619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density marker analysis of 11p15.5 in non-small cell lung carcinomas reveals allelic deletion of one shared and one distinct region when compared to breast carcinomas.
    Tran YK; Newsham IF
    Cancer Res; 1996 Jul; 56(13):2916-21. PubMed ID: 8674040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consortium study on 1280 breast carcinomas: allelic loss on chromosome 17 targets subregions associated with family history and clinical parameters.
    Phelan CM; Borg A; Cuny M; Crichton DN; Baldersson T; Andersen TI; Caligo MA; Lidereau R; Lindblom A; Seitz S; Kelsell D; Hamann U; Rio P; Thorlacius S; Papp J; Olah E; Ponder B; Bignon YJ; Scherneck S; Barkardottir R; Borresen-Dale AL; Eyfjörd J; Theillet C; Thompson AM; Larsson C
    Cancer Res; 1998 Mar; 58(5):1004-12. PubMed ID: 9500463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region.
    di Iasio MG; Calin G; Tibiletti MG; Vorechovsky I; Benediktsson KP; Taramelli R; Barbanti-Brodano G; Negrini M
    Oncogene; 1999 Feb; 18(8):1635-8. PubMed ID: 10102634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity at 11q22-q23 in breast cancer.
    Carter SL; Negrini M; Baffa R; Gillum DR; Rosenberg AL; Schwartz GF; Croce CM
    Cancer Res; 1994 Dec; 54(23):6270-4. PubMed ID: 7954477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium.
    Laake K; Launonen V; Niederacher D; Gudlaugsdottir S; Seitz S; Rio P; Champème MH; Bièche I; Birnbaum D; White G; Sztan M; Sever N; Plummer S; Osorio A; Broeks A; Huusko P; Spurr N; Borg A; Cleton-Jansen AM; van't Veer L; Benitez J; Casey G; Peterlin B; Olah E; Børresen-Dale AL
    Genes Chromosomes Cancer; 1999 Jul; 25(3):212-21. PubMed ID: 10379867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic alteration mapping on chromosome 7 in primary breast cancer.
    Bièche I; Khodja A; Driouch K; Lidereau R
    Clin Cancer Res; 1997 Jun; 3(6):1009-16. PubMed ID: 9815778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity on chromosome 11p15 during histological progression in microdissected ductal carcinoma of the breast.
    Lichy JH; Zavar M; Tsai MM; O'Leary TJ; Taubenberger JK
    Am J Pathol; 1998 Jul; 153(1):271-8. PubMed ID: 9665488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3.
    Hampton GM; Mannermaa A; Winqvist R; Alavaikko M; Blanco G; Taskinen PJ; Kiviniemi H; Newsham I; Cavenee WK; Evans GA
    Cancer Res; 1994 Sep; 54(17):4586-9. PubMed ID: 8062246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellite alterations at 5q21, 11p13, and 11p15.5 do not predict survival in non-small cell lung cancer.
    Sánchez-Céspedes M; Rosell R; Pifarré A; López-Cabrerizo MP; Barnadas A; Sánchez JJ; Lorenzo JC; Abad A; Monzó M; Navas-Palacios JJ
    Clin Cancer Res; 1997 Jul; 3(7):1229-35. PubMed ID: 9815804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation at chromosome 11q23 in human non-familial breast cancer: a microdissection microsatellite analysis.
    Koreth J; Bethwaite PB; McGee JO
    J Pathol; 1995 May; 176(1):11-8. PubMed ID: 7616353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allelic loss at the 8p22 region as a prognostic factor in large and estrogen receptor negative breast carcinomas.
    Utada Y; Haga S; Kajiwara T; Kasumi F; Sakamoto G; Nakamura Y; Emi M
    Cancer; 2000 Mar; 88(6):1410-6. PubMed ID: 10717624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3.
    Negrini M; Rasio D; Hampton GM; Sabbioni S; Rattan S; Carter SL; Rosenberg AL; Schwartz GF; Shiloh Y; Cavenee WK
    Cancer Res; 1995 Jul; 55(14):3003-7. PubMed ID: 7606718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases.
    Lindblom A; Rotstein S; Skoog L; Nordenskjöld M; Larsson C
    Cancer Res; 1993 Aug; 53(16):3707-11. PubMed ID: 8339280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromosome 11q22.3-q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions.
    Launonen V; Stenbäck F; Puistola U; Bloigu R; Huusko P; Kytölä S; Kauppila A; Winqvist R
    Gynecol Oncol; 1998 Nov; 71(2):299-304. PubMed ID: 9826475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of loss of alleles on the short arms of chromosomes 11 and 17 with metastasis of primary breast cancer to lymph nodes.
    Takita K; Sato T; Miyagi M; Watatani M; Akiyama F; Sakamoto G; Kasumi F; Abe R; Nakamura Y
    Cancer Res; 1992 Jul; 52(14):3914-7. PubMed ID: 1617666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel deletion regions on chromosome arms 2q and 6p in breast carcinomas by amplotype analysis.
    Piao Z; Lee KS; Kim H; Perucho M; Malkhosyan S
    Genes Chromosomes Cancer; 2001 Feb; 30(2):113-22. PubMed ID: 11135428
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity at chromosome regions 22q11-12 and 11p15.5 in renal rhabdoid tumors.
    Schofield DE; Beckwith JB; Sklar J
    Genes Chromosomes Cancer; 1996 Jan; 15(1):10-7. PubMed ID: 8824720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.